Results 131 to 140 of about 2,012 (174)

Comparative efficacy and safety of first-line immunotherapy- and targeted therapy-based regimens for advanced gastric and gastroesophageal junction cancer: a network meta-analysis. [PDF]

BMC Cancer
Wang W, Zhang X, Sun X, Wang L.
europepmc   +1 more source

Chinese consensus on first-line precision therapy for advanced gastric cancer. [PDF]

Innovation (Camb)
Zhang X, Sheng W, Xie T, Peng Z, Liang H, Li E, Wang F, Zhang J, Liu T, Zhu X, Cai M, Wu Y, Deng T, Gou H, Sun Y, Wei J, He Y, Huang D, Ying J, Bai W, Jin X, Kang W, Li N, Li Z, Liu J, Lu Y, Qiu H, Qiu M, Qu X, Song Y, Sun Y, Sun Y, Wang J, Wang Y, Xu H, Yin F, Zhao L, Liu Y, Shen L, Chinese Clinical Society Gastric Cancer Committee, China Anti-Cancer Association Cancer Informatics Management Committee, China Anti-Cancer Association Cancer Pathology Specialized Committee, China Anti-Cancer Association Committee of Cancer Precision Therapy.   +42 more
europepmc   +1 more source

From Tumor Biology to Clinical Perspectives: Novel Biomarkers and Therapeutic Insights in Gastric Cancer. [PDF]

Oncol Res
Cheng X, Ma Y, Yan J, Zhang Y, Su R, Tao X, Zhao J, Du P.   +7 more
europepmc   +1 more source

Fibroblast Growth Factors in Lung Development and Regeneration: Mechanisms and Therapeutic Potential. [PDF]

Cells
Baran K, Skrzynska K, Czyrek AA, Wittek A, Krowarsch D, Szlachcic A, Zakrzewska M, Chudzian J.   +7 more
europepmc   +1 more source

Translating Gastric Cancer Genomics into Targeted Therapy: Mechanistic Insights from Animal Models and Patient-Derived Systems. [PDF]

Cells
Shyu RY, Wang LK, Tsai FM.
europepmc   +1 more source

Erratum: Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial. [PDF]

JCO Precis Oncol
Rha SY, Zhang Y, Elme A, Cid RP, Alacacioglu A, Ziogas DC, Shitara K, Ranceva A, Nemecek R, Santoro A, Calderon CA, Korphaisarn K, Davis T, Zahlten-Kuemeli A, Conn C, Tan M, Honeycutt H, Wainberg ZA.   +17 more
europepmc   +1 more source

Molecular classification and precision therapy in gastric cancer: Current advances and future perspectives (Review). [PDF]

Oncol Rep
Xia S, Zhang X, Tang L, Li A, Chen J, Tao Z.   +5 more
europepmc   +1 more source

Advancing Ocular Safety Profile Assessment: A Novel Grading Scale for Ocular Adverse Reactions Associated with Bemarituzumab. [PDF]

Ophthalmol Ther
Farooq AV, Kaur S, Hundal P, Burke M, Sulaiman R, Zahlten-Kümeli A, Raoof S, Li Z, Murias Dos Santos T, Huang XJ, Colby K.   +10 more
europepmc   +1 more source

FGFR as a Predictive Marker for Targeted Therapy in Gastrointestinal Malignancies: A Systematic Review. [PDF]

J Gastrointest Cancer
Seraji N, Berger I.
europepmc   +1 more source